Delivery Order SPE2DB20D2002-SPE2DB22FL32Y
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,615.05 for the supply of 4556120380 - BROMSITE 0.075% EYE DROPS 5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 2, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract, valued at $3,547.25, is a firm fixed-price delivery order with a completion date of December 11, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $2,699.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., for the procurement of BROMSITE 0.075% eye drops. This award was not designated as a set-aside contract. Amerisourcebergen Drug Corp. is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, including the Department of Defense and Department of Veterans Affairs. The...
- This federal contract award, valued at $6,581.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Bromsite 0.075% eye drops, a specialty medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,024.26 for Bromfenac Sodium 0.09% eye drops. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of July 29, 2021. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award with a ceiling value of $4,421.74 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of BROMSITE 0.075% eye drops in 5 milliliter bottles, to be delivered by March 16, 2023. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,227.06 for the supply of Bromfenac Sodium 0.09% eye drops. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,535.81 delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award is for the supply of Fluorometholone 0.1% eye drops, a pharmaceutical product used to treat various eye conditions. There is no set-aside designation, indicating this was an open competition. The DLA, a defense agency, is the...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL32YDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential medical commodities, including specialty drugs, to federal agencies such as the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/14/22 |